|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.76 CHF | -2.01% |
|
-1.77% | -0.04% |
| 07:28am | Novartis reports positive interim results for Fabhalta | CF |
| 05:26am | Novartis' Investigational Kidney Disease Drug Shows Reduced Disease Marker in Late-stage Trial | MT |
(MORE TO FOLLOW) Dow Jones Newswires
January 04, 2022 01:15 ET (06:15 GMT)
| 1st Jan change | Capi. | |
|---|---|---|
| -0.04% | 207B | |
| +28.79% | 676B | |
| +23.78% | 559B | |
| -5.84% | 356B | |
| +15.75% | 320B | |
| +4.32% | 286B | |
| +3.28% | 213B | |
| -8.96% | 199B | |
| -10.00% | 147B | |
| -7.82% | 142B |
NOVARTIS AG 
